» Articles » PMID: 18554778

Antioxidant Potential by Arabinoxylan Rice Bran, MGN-3/biobran, Represents a Mechanism for Its Oncostatic Effect Against Murine Solid Ehrlich Carcinoma

Overview
Journal Cancer Lett
Specialty Oncology
Date 2008 Jun 17
PMID 18554778
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently examined the oncolytic effect of arabinoxylan rice bran, MGN-3/biobran, against solid Ehrlich carcinoma (SEC)-bearing mice via immune-modulation and apoptosis [N.K. Badr El-din, E. Noaman, M. Ghoneum, In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/biobran on Ehrlich carcinoma-bearing mice, Nutr. Cancer 60 (2) (2008) 235-244]. In the present study, we examined the antioxidant system as another possible mechanism through which MGN-3 exerts its oncostatic potential. Female albino mice were inoculated intramuscularly in the right thigh with Ehrlich ascites carcinoma (EAC) cells. MGN-3 (25 mg/kg body weight) was injected intraperitoneally (i.p.) six times a week for 25 days into mice at either day 4 or day 11 post-EAC cell inoculation. Tumor growth, lipid peroxidation (LPx), glutathione (GSH) contents, the activity of the antioxidant scavenger enzymes, and alterations in gene expression were examined. MGN-3 efficiently suppressed the growth of tumors, which was associated with normalization of the LPx levels and augmentation of GSH contents. MGN-3 enhanced the activity of the endogenous antioxidant scavenging enzymes -- superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and glutathione-S-transferase (GST) -- in blood, liver, and tumor tissue. Similarly it up-regulated the expression of GPx, SOD1 and CAT mRNA in the liver. The effect of MGN-3 was more pronounced when treated early, at day 4 of tumor cell inoculation, as compared to later treatment at 11 days. In conclusion, MGN-3-induced oncostatic activity by modulating lipid peroxidation, augmenting the antioxidant defense system and protecting against oxidative stress.

Citing Articles

Molecular docking and / studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.

Alqahtani N, Alfaifi M, Shati A A, Elbehairi S, Saleh A, Kotb E RSC Adv. 2024; 14(52):39027-39039.

PMID: 39659603 PMC: 11629753. DOI: 10.1039/d4ra06398h.


Improvement in Epigenetic Aging Clock Induced by BioBran Containing Rice Kefiran in Relation to Various Biomarkers: A Pilot Study.

Kawakami S, Ninomiya R, Maeda Y Int J Mol Sci. 2024; 25(12).

PMID: 38928040 PMC: 11203851. DOI: 10.3390/ijms25126332.


Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.

Ooi S, Micalos P, Kim J, Pak S Pharm Biol. 2024; 62(1):367-393.

PMID: 38745507 PMC: 11097709. DOI: 10.1080/13880209.2024.2349042.


Biobran-loaded core/shell nanofibrous scaffold: a promising wound dressing candidate.

Kenawy E, El-Moaty M, Ghoneum M, Soliman H, El-Shanshory A, Shendy S RSC Adv. 2024; 14(7):4930-4945.

PMID: 38327812 PMC: 10848241. DOI: 10.1039/d3ra08609g.


Modified Rice Bran Arabinoxylan by Mycelial Enzyme as an Immunoceutical for Health and Aging-A Comprehensive Literature Review.

Ooi S, Micalos P, Pak S Molecules. 2023; 28(17).

PMID: 37687141 PMC: 10488663. DOI: 10.3390/molecules28176313.